T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Warrior Met Coal
HCC
$4.98B
| $78.9M | 0.01% |
1,299,563
+30,053
| +2% | +$1.82M |
|
602
Performance Food Group
PFGC
$16.4B
| $78.7M | 0.01% |
1,054,625
+16,580
| +2% | +$1.22M |
|
|
LNW
603
DELISTED
Light & Wonder
LNW
| $78.3M | 0.01% |
767,155
+388,781
| +103% | +$35.1M |
|
604
Iovance Biotherapeutics
IOVA
$2.95B
| $78.1M | 0.01% |
5,267,864
+1,991,262
| +61% | +$23.2M |
|
605
Air Products & Chemicals
APD
$68B
| $77.8M | 0.01% |
321,285
-368,638
| -53% | -$90.3M |
|
606
Apogee Therapeutics
APGE
$10.2B
| $77.8M | 0.01% |
1,170,327
+399,646
| +52% | +$17.4M |
|
607
Simpson Manufacturing
SSD
$8B
| $77.6M | 0.01% |
378,313
+4,195
| +1% | +$813K |
|
608
Omnicom Group
OMC
$24.2B
| $77.2M | 0.01% |
798,075
-159,201
| -17% | -$14.3M |
|
609
Vontier
VNT
$4.47B
| $76.9M | 0.01% |
1,695,280
+329,191
| +24% | +$12.8M |
|
610
Aflac
AFL
$60.7B
| $75.8M | 0.01% |
882,906
+12,357
| +1% | +$1.01M |
|
611
SPS Commerce
SPSC
$2.86B
| $75.6M | 0.01% |
408,846
-42,160
| -9% | -$7.78M |
|
612
Kadant
KAI
$3.91B
| $75.5M | 0.01% |
230,117
-916
| -0.4% | -$276K |
|
613
Insulet
PODD
$10.2B
| $74.7M | 0.01% |
435,924
-119,193
| -21% | -$22.2M |
|
|
SGI
614
Somnigroup International
SGI
$14B
| $74.7M | 0.01% |
1,314,131
-2,219
| -0.2% | -$116K |
|
615
ON Semiconductor
ON
$31.8B
| $74.6M | 0.01% |
1,013,819
-1,116,033
| -52% | -$85.4M |
|
616
Royal Gold
RGLD
$19.1B
| $74.3M | 0.01% |
609,760
+422,026
| +225% | +$47.7M |
|
617
Acadia Pharmaceuticals
ACAD
$4.89B
| $74M | 0.01% |
3,999,550
-1,178,959
| -23% | -$29.2M |
|
618
Matador Resources
MTDR
$6.39B
| $73.8M | 0.01% |
1,104,791
+53,322
| +5% | +$3.17M |
|
|
AZEK
619
DELISTED
The AZEK Co
AZEK
| $73.6M | 0.01% |
1,466,145
+587,107
| +67% | +$25.6M |
|
620
Procept Biorobotics
PRCT
$1.26B
| $72.5M | 0.01% |
1,467,659
-38,000
| -3% | -$1.81M |
|
621
Primerica
PRI
$9.62B
| $72M | 0.01% |
284,524
-5,765
| -2% | -$1.36M |
|
622
Watts Water Technologies
WTS
$12.8B
| $71.9M | 0.01% |
338,378
+1,049
| +0.3% | +$212K |
|
623
DraftKings
DKNG
$12.6B
| $71.6M | 0.01% |
1,576,608
-13,844
| -0.9% | -$563K |
|
624
Nexstar Media Group
NXST
$5.81B
| $71.4M | 0.01% |
414,367
-20,685
| -5% | -$3.47M |
|
625
Ford
F
$55.4B
| $71M | 0.01% |
5,349,276
+59,082
| +1% | +$716K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.